Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-004-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Please see Analogue Approach
Cross-reference
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Please see Analogue Approach
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- C57BL
- Remarks:
- 6
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River - Calco CO, Italy
- Age at study initiation: no data
- Weight at study initiation: 18 - 20 g
- Assigned to test groups randomly: yes
- Fasting period before study: no data
- Housing: in groups of 5 in transparent polycarbonate cages (dimensions 355x235x190 mm)
- Diet (e.g. ad libitum): standard pellet complete diet ad libitum supplied by the authorized breeder Nossan
- Water (e.g. ad libitum): filtered tap water from local network ad libitum
- Acclimation period: 5 days (during this persiod they were observed daily)
ENVIRONMENTAL CONDITIONS
The housing room conditions of temperature and humidity were maintained by the conditioning plant and continuously recorded, no further details mentioned
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: May 10, 1993 To: May 13, 1993 - Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: sesame seed oil
- Justification for choice of solvent/vehicle: no data
- Concentration of test material in vehicle: 250 mg/mL
- Amount of vehicle (if gavage or dermal): 50 mL/kg bw - Details on exposure:
- A solution was prepared in sesame seed oil at a concentration of 250 mg/mL. Animals were treated in a single dose by intraperitoneal injection.
- Duration of treatment / exposure:
- 24, 48 and 72 hours
- Frequency of treatment:
- single intraperitoneal injection
- Post exposure period:
- none
- Remarks:
- Doses / Concentrations:
12500 mg/kg bw
Basis:
nominal conc. - No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide in physiological saline
- Justification for choice of positive control(s): no data
- Route of administration: intraperitoneal injection
- Doses / concentrations: volume administration: 50 mL/kg bw; dose: 75 mg/kg bw - Tissues and cell types examined:
- Preparation of the bone marrow were made on slides.
Poly- and normochromatic erythrocytes and micronucleated polychromatic erythrocytes were counted. - Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: no data
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): 24, 48 and 72 hours
Sacrifice:
Animals were sacrified, by displacement of cervical vertebran.
DETAILS OF SLIDE PREPARATION: Thigh-bones were removed and cleaned from muscles. The heads of the femur was removed and foetal calf serum was introduced in the femur channel by means of a thin needle. The bone marrow cells coming out from the other side of the thigh-bone were collected in a test tube, then centrifugated for 10 min at 1000 rpm. The supernatant was removed and cells resuspended in 10 µL of foetal calf serum, smeared on slides, air-dried and stained with May Grunland and Giemsa solutions.
Smears dyeing:
Once dried, slides were dyed as follows:
immersion in May Grunland solution for 3 minutes;
wash in distilled water;
immersion in Giemsa solution, diluted 1:6 in distilled
water for 10 minutes;
washing in distilled water;
air drying
METHOD OF ANALYSIS: The slidas wer observed with an optic microscope, choosing the areas showed the best distribution of cells and a perfect staining. For each animal 1000 polychromatic erythrocytes were counted, and the frequence of normochromatic and of micronucleated polychromatic erythrocytes were recorded. - Evaluation criteria:
- The following data were evaluated:
- difference between the number of micronucleated polychromatic erythrocytes in the treatment group and negative control
- difference between the number of micronucleated polychromatic erythrocytes in the treatment group and positive control
- difference between the number of micronucleated polychromatic erythrocytes in the negative control and positive control
- difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and negative control
- difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and positive control
- difference between the proportion of polychromatic/normochromatic erythrocytes in the negative control and positive control - Statistics:
- The data obtained from the proportional relationship between the polychromatic erythrocytes and the normochromatic erythrocytes was statistically evaluated by means of Student's t-test with 95% probability.
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- The difference between the number of micronucleated polychromatic erythrocytes in the treatment group and negative control is not significant.
The difference between the number of micronucleated polychromatic erythrocytes in the treatment group and positive control is significant.
The difference between the number of micronucleated polychromatic erythrocytes in the negative control and positive control is significant.
The difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and negative control is not significant.
The difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and positive control is significant.
The difference between the proportion of polychromatic/normochromatic erythrocytes in the negative control and positive control is significant. - Conclusions:
- Interpretation of results: negative
The test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters did not cause damage to this mitotic system under the conditions of the study. - Executive summary:
In order to verify its possible mutagenic effect, the test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters was administered to 90 mice C57 (45 males and 45 females) according to EEC Directive 92/69. 30 were treated with the test material (12500 mg/kg), 30 treated with Cyclophosphamide (75 mg/kg bw) as positive control and 30 treated with sesame seed oil (50 mL/kg bw) as negative control. The 90 mice were sacrificed at the following times:
- 30 (10 from each group) 24 hours after the beginning of treatment
- 30 (10 from each group) 48 hours after the beginning of treatment
- 30 (10 from each group) 72 hours after the beginning of treatment.
After the sacrifice, the bone marrow of each animal was extracted, smeared on a slide, stained and observed with a microscope. For each animal 1000 polychromatic erythrocytes were counted and the frequence of normochromatic and micronucleated polychromatic erythrocytes were recorded. The data obtained from the proportional relationship between the polychromatic erythrocytes and the normochromatic erythrocytes was statistically evaluated by means of Student's t-test. The following results 24 and 48 hours after the beginning of the test were obtained:
- the difference between the number of micronucleated polychromatic erythrocytes in the treatment group and negative control is not significant.
- the difference between the number of micronucleated polychromatic erythrocytes in the treatment group and positive control is significant
- the difference between the number of micronucleated polychromatic erythrocytes in the negative control and positive control is significant
- the difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and negative control is not significant
- the difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and positive control is significant
- the difference between the proportion of polychromatic/normochromatic erythrocytes in the negative control and positive control is significant.
It was concluded that the test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters did not have a mutagenic effect on this mitotic system under the conditions of the study.
Table #1: Mean of micronucleated polychromatic erythrocytes | ||||||||||||
Concentration [mg/kg bw] |
Sampling time | |||||||||||
24 h | 48 h | 72 h | ||||||||||
male | female | male |
female |
male |
female |
|||||||
12500 |
1.40 ± 1.14 |
1.40 ± 0.89 |
1.20 ± 0.83 |
1.20 ± 0.44 |
1.00 ± 0.71 |
0.80 ± 0.45 |
||||||
Positive control |
61.2 ± 6.06 |
59.4 ± 2.61 |
62.2 ± 6.22 |
61.8 ± 3.35 | 64.4 ± 5.86 | 63.4 ± 2.61 | ||||||
Negative control | 1.60 ± 1.51 | 1.80 ± 0.83 | 1.80 ± 0.83 | 1.20 ± 1.09 | 2.00 ± 1.41 | 0.40 ± 0.89 | ||||||
Table #2: Ratio polychromatic/normochromatic erythrocytes | ||||||||||||
Concentration [mg/kg bw] |
Sampling time | |||||||||||
24 h | 48 h | 72 h | ||||||||||
male | female | male | female | male | female | |||||||
12500 | 2.30 ± 0.28 | 2.47 ± 0.30 | 2.16 ± 0.41 | 2.41 ± 0.39 | 2.20 ± 0.31 | 2.35 ± 0.41 | ||||||
Positive control | 0.99 ± 0.10 | 0.96 ± 0.08 | 0.98 ± 0.18 | 0.94 ± 0.12 | 0.85 ± 0.11 | 0.81 ± 0.07 | ||||||
Negative control | 2.20 ± 0.40 | 2.30 ± 0.34 | 2.23 ± 0.23 | 2.38 ± 0.32 | 2.23 ± 0.33 | 2.26 ± 0.43 | ||||||
* = only platelets and blasts were observed | ||||||||||||
Data source
Materials and methods
Test material
- Reference substance name:
- Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-,C12-13-branched alkyl esters
- EC Number:
- 947-004-7
- Molecular formula:
- C28H56O6 - C29H58O6 - C30H60O6
- IUPAC Name:
- Butanedioic acid, 2,3-dihydroxy- [R-(R*,R*)]-,C12-13-branched alkyl esters
- Test material form:
- liquid
- Details on test material:
- product
Constituent 1
Administration / exposure
- Route of administration:
- intraperitoneal
- No. of animals per sex per dose:
- 5
Examinations
- Tissues and cell types examined:
- P
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- The difference between the number of micronucleated polychromatic erythrocytes in the treatment group and negative control is not significant.
The difference between the number of micronucleated polychromatic erythrocytes in the treatment group and positive control is significant.
The difference between the number of micronucleated polychromatic erythrocytes in the negative control and positive control is significant.
The difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and negative control is not significant.
The difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and positive control is significant.
The difference between the proportion of polychromatic/normochromatic erythrocytes in the negative control and positive control is significant.
Any other information on results incl. tables
Table #1: Mean of micronucleated polychromatic erythrocytes | ||||||||||||
Concentration [mg/kg bw] |
Sampling time | |||||||||||
24 h | 48 h | 72 h | ||||||||||
male | female | male |
female |
male |
female |
|||||||
12500 |
1.40 ± 1.14 |
1.40 ± 0.89 |
1.20 ± 0.83 |
1.20 ± 0.44 |
1.00 ± 0.71 |
0.80 ± 0.45 |
||||||
Positive control |
61.2 ± 6.06 |
59.4 ± 2.61 |
62.2 ± 6.22 |
61.8 ± 3.35 | 64.4 ± 5.86 | 63.4 ± 2.61 | ||||||
Negative control | 1.60 ± 1.51 | 1.80 ± 0.83 | 1.80 ± 0.83 | 1.20 ± 1.09 | 2.00 ± 1.41 | 0.40 ± 0.89 | ||||||
Table #2: Ratio polychromatic/normochromatic erythrocytes | ||||||||||||
Concentration [mg/kg bw] |
Sampling time | |||||||||||
24 h | 48 h | 72 h | ||||||||||
male | female | male | female | male | female | |||||||
12500 | 2.30 ± 0.28 | 2.47 ± 0.30 | 2.16 ± 0.41 | 2.41 ± 0.39 | 2.20 ± 0.31 | 2.35 ± 0.41 | ||||||
Positive control | 0.99 ± 0.10 | 0.96 ± 0.08 | 0.98 ± 0.18 | 0.94 ± 0.12 | 0.85 ± 0.11 | 0.81 ± 0.07 | ||||||
Negative control | 2.20 ± 0.40 | 2.30 ± 0.34 | 2.23 ± 0.23 | 2.38 ± 0.32 | 2.23 ± 0.33 | 2.26 ± 0.43 | ||||||
* = only platelets and blasts were observed | ||||||||||||
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
The test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters did not cause damage to this mitotic system under the conditions of the study. - Executive summary:
In order to verify its possible mutagenic effect, the test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters was administered to 90 mice C57 (45 males and 45 females) according to EEC Directive 92/69. 30 were treated with the test material (12500 mg/kg), 30 treated with Cyclophosphamide (75 mg/kg bw) as positive control and 30 treated with sesame seed oil (50 mL/kg bw) as negative control. The 90 mice were sacrificed at the following times:
- 30 (10 from each group) 24 hours after the beginning of treatment
- 30 (10 from each group) 48 hours after the beginning of treatment
- 30 (10 from each group) 72 hours after the beginning of treatment.
After the sacrifice, the bone marrow of each animal was extracted, smeared on a slide, stained and observed with a microscope. For each animal 1000 polychromatic erythrocytes were counted and the frequence of normochromatic and micronucleated polychromatic erythrocytes were recorded. The data obtained from the proportional relationship between the polychromatic erythrocytes and the normochromatic erythrocytes was statistically evaluated by means of Student's t-test. The following results 24 and 48 hours after the beginning of the test were obtained:
- the difference between the number of micronucleated polychromatic erythrocytes in the treatment group and negative control is not significant.
- the difference between the number of micronucleated polychromatic erythrocytes in the treatment group and positive control is significant
- the difference between the number of micronucleated polychromatic erythrocytes in the negative control and positive control is significant
- the difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and negative control is not significant
- the difference between the proportion of polychromatic/normochromatic erythrocytes in the treatment group and positive control is significant
- the difference between the proportion of polychromatic/normochromatic erythrocytes in the negative control and positive control is significant.
It was concluded that the test material Butanedioic acid, 2,3-dihydroxy-di-C14-C15 alkyl esters did not have a mutagenic effect on this mitotic system under the conditions of the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
